Brian Gallagher

Brian Gallagher

Direktor/Vorstandsmitglied bei
Nimbus Apollo, Inc.
56 Jahre
Health Technology
Finance
Consumer Services

Profil

Brian M.
Gallagher
's current jobs include being a Director at eFFECTOR Therapeutics Operations, Inc., Nimbus Apollo, Inc., and Slate Bio, Inc. Formerly, Dr. Gallagher served as the Chairman at eFFECTOR Therapeutics, Inc. from 2021 to 2024.
He was also a Director at CalciMedica Subsidiary, Inc. from 2013 to 2018, Aileron Therapeutics, Inc. from 2010 to 2018, Nimbus Therapeutics LLC from 2011 to 2018, Translate Bio, Inc. from 2011 to 2019, River Vision Development Corp.
from 2012 to 2017, Navitor Pharmaceuticals, Inc. from 2014 to 2018, and GSK Equity Investments Ltd. from 2010 to 2018.
Additionally, he held positions as a Director at Dicerna Pharmaceuticals, Inc., SpringLeaf Therapeutics, Inc., and Constellation Pharmaceuticals, Inc. Dr. Gallagher's education includes graduate and doctorate degrees from the University of Michigan.

Aktive Positionen von Brian Gallagher

UnternehmenPositionBeginn
Direktor/Vorstandsmitglied -
Direktor/Vorstandsmitglied -
Direktor/Vorstandsmitglied -

Ehemalige bekannte Positionen von Brian Gallagher

UnternehmenPositionEnde
EFFECTOR THERAPEUTICS, INC. Vorsitzender 21.06.2024
Direktor/Vorstandsmitglied 31.12.2022
Private Equity Investor 01.01.2022
TRANSLATE BIO, INC. Direktor/Vorstandsmitglied 01.01.2019
REIN THERAPEUTICS INC. Direktor/Vorstandsmitglied 19.03.2018
Sehen Sie sich die Erfahrung von Brian Gallagher im Detail an

Ausbildung von Brian Gallagher

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Beziehungen

60

Beziehungen ersten Grades

21

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Unternehmensverbindungen

Private Unternehmen21

Commercial Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Retail Trade

Health Technology

Health Technology

Health Technology

Health Technology

Finance

Consumer Services

Consumer Services

Finance

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

  1. Börse
  2. Insider
  3. Brian Gallagher